Tadashi Matsuura

Also affiliated with Abterra Biosciences (United States), Ecogenomics (Japan), Hokkaido hospital, Osaka Metropolitan University, Tokyo Metropolitan University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors”.

Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0037

N/A

0DataRank · unranked

30 citations

William D. Erwin, Osama Mawlawi, Asa McCoy, David Wages, Catherine Wheeler +23 more

Data from Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

(2023)10.1158/1078-0432.c.6529733

N/A

0DataRank · unranked

0 citations

William D. Erwin, Osama Mawlawi, Asa McCoy, David Wages, Catherine Wheeler +23 more

Data from Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

(2023)10.1158/1078-0432.c.6529733.v1

N/A

0DataRank · unranked

0 citations

William D. Erwin, Osama Mawlawi, Asa McCoy, David Wages, Catherine Wheeler +23 more